XBIO

Value 202020212022202320242025 TTM Total revenue 436.94 K1.16 M1.71 M2.54 M2.5 M2.98 M 2.98 M Gross profit 436.94 K1.16 M1.71 M2.54 M2.5 M2.98 M 2.98 M Operating expenses 14.37 M6.91 M8.42 M7.06 M6.7 M5.81 M 5.81 M Selling/general/admin expenses 3.4 M3.74 M3.65 M3.56 M3.42 M2.75 M 2.75 M Research & development 1.73 M3.16 M4.77 M3.49 M3.29 M3.07 M 3.07 M Operating income -13.94 M-5.75 M-6.72 M-4.52 M-4.2 M-2.83 M -2.83 M Non-Operating Income, Total 125.68 K101.59 K165.55 K381.14 K244.15 K153.72 K 153.72 K Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 126.17 K100.47 K167.15 K355.76 K249.86 K148 K 148 K Unusual income/expense -4921 119-1 59725.38 K-5 7085 725 5 725 Pretax income -13.67 M-5.65 M-6.55 M-4.13 M-3.96 M-2.68 M -2.68 M Equity in earnings —————— — Taxes -2.92 M00000 0 Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -10.89 M-5.65 M-6.55 M-4.13 M-3.96 M-2.68 M -2.68 M Discontinued operations —————— — Net income -10.89 M-5.65 M-6.55 M-4.13 M-3.96 M-2.68 M -2.68 M Dilution adjustment 0————— — Preferred dividends 0————— — Diluted net income available to common stockholders -10.89 M-5.65 M-6.55 M-4.13 M-3.96 M-2.68 M -2.68 M Basic earnings per share (Basic EPS) ——-4.6-2.71-2.57-1.58 -1.58 Diluted earnings per share (Diluted EPS) ——-4.6-2.71-2.57-1.58 -1.58 Average basic shares outstanding ——1.42 M1.53 M1.54 M1.7 M 6.33 M Diluted shares outstanding ——1.42 M1.53 M1.54 M1.7 M 6.33 M EBITDA -13.94 M-5.75 M———— — EBIT -13.94 M-5.75 M-6.72 M-4.52 M-4.2 M-2.83 M -2.83 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 7570———— —